Oral administration of alpha-lipoic acid did not affect lipid peroxidation and antioxidant biomarkers in rheumatoid arthritis patients
Abstract
Abstract. Rheumatoid arthritis (RA) is a chronic inflammatory disease in which oxidative stress could play a substantial pathological role. Alpha-lipoic acid (ALA) has been known as a “universal” and “ideal” antioxidant. The purpose of this study was to investigate the effects of oral administration of Alpha-lipoic acid (ALA) on lipid peroxidation and antioxidant biomarkers in Rheumatoid arthritis (RA) patients. The study was a randomized, double-blinded, placebo-controlled clinical trial. 70 RA patients were randomized 1:1 to two groups using blocked randomization method and received 1200 mg/day ALA or placebo for 8 weeks. Fasting blood samples were obtained before and after the intervention to analyze total antioxidant capacity (TAC), antioxidant enzymes [superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and arylesterase (ARE) activities] and malondialdehyde (MDA). We observed significant increase in serum TAC (0.11 mmol/L; p=0.033) and ARE (13.76 U/mL; p=0.046) and significant decline in MDA (−0.36 nmol/L; p=0.002), in ALA group. However, these changes in ALA-treated group were not statistically significant when compared with placebo-treated group (p > 0.05). Also, within- and between-group differences of whole blood SOD and GSH-Px were not statistically significant (p > 0.05). In conclusion, unexpectedly, ALA therapy did not affect the oxidative status of RA patients in the present clinical trial. It seems that more comprehensive clinical trials in RA patients are still warranted to clarify the effectiveness of ALA which has been known as a potent antioxidant.
References
1 (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581.
2 (2010) Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal. 12, 743–785.
3 (2014) Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity. Mol Cell Biochem. 391, 225–232. https://doi.org/10.1007/s11010-014-2006-6
4 (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 118, 3537.
5 (2008) Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol. 152, 415–422.
6 (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 350, 2591–2602.
7 (2010) Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chem. 122, 987–996.
8 (1974) Multienzyme complexes. Acc Chem Res. 7, 40–46.
9 (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 1790, 1149–1160.
10 (2008) Is α-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life. 60, 362–367.
11 (2002) Alpha-lipoic acid modulates NF-κB activity in human monocytic cells by direct interaction with DNA. Exp Gerontol. 37, 401–410.
12 (2007) Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int. 27, 225–233.
13 (2010) Dietary alpha lipoic acid supplementation prevents synovial inflammation and bone destruction in collagen-induced arthritic mice. Rheumatol Int. 31, 1583–1590.
14 (2009) Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr. 28, 56–62.
15 (2015) Effects of alpha-Lipoic acid supplementation on inflammatory biomarkers and matrix metalloproteinase-3 in rheumatoid arthritis patients. J Am Coll Nutr. 34, 310–317.
16 (1953) Serum esterases. 1. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination. Biochem J. 53, 110–117.
17 (2003) Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin Chem. 49, 690–692.
18 (2008) Antioxidant intervention in rheumatoid arthritis: results of an open pilot study. Clin Rheumatol. 27, 771–775.
19 (2011) The evaluation of concurrent supplementation with vitamin E and omega-3 fatty acids on plasma lipid per oxidation and antioxidant levels in patients with rheumatoid arthritis. Internet J Rheumatol. 7.
20 (2015) α-lipoic acid protects against cerebral ischemia/reperfusion-induced injury in rats. Mol Med Rep. 11, 3659–3665.
21 (2011) Immunomodulatory effect of DL-α-lipoic acid in aged rats. Exp Gerontol. 46, 709–715.
22 (2014) Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial. Nutr Neurosci. 17, 16–20.
23 (2010) Effects of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome. Diabetes Sci Technol. 4, 359–364.
24 (1988) Follow-up study of lipid peroxides, superoxide dismutase and glutathione peroxidase in the synovial membrane, serum and liver of young and old mice with collagen-induced arthritis. Life Sci. 43, 1887–1896.
25 (2004) Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men. Br J Clin Pharmacol. 58, 243–248.
26 (2014) Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with schizophrenia. Psychiatr Danub. 26, 205–213.
27 (2014) α-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction. Eur Rev Med Pharmacol Sci. 18, 3715–3719.
28 (2014) Effects of dietary α-lipoic acid, acetyl-l-carnitine, and sex on antioxidative ability, energy, and lipid metabolism in broilers. Poult Sci. 93, 2809–2817.
29 (2001) Effect of dl-α-lipoic acid on glutathione metabolic enzymes in aged rats. Exp Gerontol. 37, 81–87.
30 (2000) Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-α-lipoic acid. Eur J Pharmacol. 398, 139–146.
31 (2007) Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol. 26, 342–348.
32 (2011) Beta-carotene, vitamin E, MDA, glutathione reductase and arylesterase activity levels in patients with active rheumatoid arthritis. Iran J Public Health. 40, 102–109.
33 (2012) Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial. Arch Iran Med. 15, 549–552.
34 (2005) Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem. 38, 951–955.
35 (2013) Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes. Rev Diabet Stud. 10, 58–67.
36 (2013) Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy. Int J Vitam Nutr Res. 83, 77–85.
37 (2012) Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr. 22, 244–250.
38 (2009) Effect of alpha - lipoic acid on LPS-induced oxidative stress in the heart. J Physiol Pharmacol. 60, 61–68.